Peptide Compass · Research

Semax: research, prices and suppliers

A synthetic ACTH-derived heptapeptide, approved in Russia for neuroprotection and studied in research on cognition and stress adaptation.

Sources and dates are stated with individual entries. This new presentation is not a complete re-investigation of all data.

Semax is a heptapeptide derived from the ACTH(4-10) fragment of the stress hormone ACTH, approved as a medication for ischemic stroke in Russia. Research also examines it in relation to neuroplasticity and cognitive function, without activating the cortisol axis.

Facts

  • CAS number: 80714-61-0
  • Molecular weight: 813.9 g/mol
  • Amino acids: 7
  • Purity specification: ≥ 98 % (HPLC, commercial standard)

Evidence

  • In a rat study, a single intranasal application of semax increased hippocampal BDNF protein levels 1.4-fold and TrkB phosphorylation 1.6-fold. PubMed ID 14556513
  • In the same fMRI study with 52 healthy participants, semax also showed altered functional connectivity between the amygdala and temporal cortex, with effects that were in part distinguishable from selank. Panikratova KR et al. 2020, Doklady Biological Sciences, Bd. 490, S. 9-11

Frequently asked questions

Does semax act like a classic nootropic?


Research links semax primarily to neuroprotective and BDNF-related effects, less to an acute focus effect like classic stimulants.

Is semax the same as selank?


No, both are related Russian peptides with different origins. Semax derives from ACTH and is mainly linked to neuroprotection, selank from tuftsin and mainly to anxiety regulation.

Is semax legally available in Germany?


Semax is not approved as a medication in Germany or the EU and is offered exclusively as a research chemical for laboratory purposes, not for human use.

Documented prices

Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.

List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.

VendorPackList pricePrice/mgRecordedSource
Peptide Shop Deutschland5 mg24.99 EUR5.0 EUR/mg2026-09-15Product page · Ad
Peptide Labz10 mg20 EUR2.0 EUR/mg2026-09-15Product page · Ad
Bio BoostX10 mg29.95 EUR3.0 EUR/mg2026-09-15Product page · Ad
Peptidwerk10 mg29.95 EUR3.0 EUR/mg2026-09-15Product page · Ad
ELYVERA (Europeptides)10 mg33.9 EUR3.39 EUR/mg2026-09-15Product page · Ad
Smart Peptides10 mg34.9 EUR3.49 EUR/mg2026-09-15Product page · Ad
Particle Peptides10 mg39.99 EUR4.0 EUR/mg2026-09-15Product page · Ad
Beyond Peptides10 mg43.28 EUR4.33 EUR/mg2026-09-15Product page · Ad
Peak Peptide10 mg49.9 EUR4.99 EUR/mg2026-09-15Product page · Ad
Europa-Peptide10 mg57.9 EUR5.79 EUR/mg2026-09-15Product page · Ad
Peptide Shop Deutschland10 mg59 EUR5.9 EUR/mg2026-09-15Product page · Ad
DN Lab Research15 mg95 EUR6.33 EUR/mg2026-09-15Product page · Ad
Bio BoostX30 mg69.95 EUR2.33 EUR/mg2026-09-15Product page · Ad
Chameleon Peptides5 mg39.6 USD7.92 USD/mg2026-09-15Product page · Ad
BioCollex10 mg45 USD4.5 USD/mg2026-09-15Product page · Ad
Protide Health10 mg60 USD6.0 USD/mg2026-09-15Product page · Ad
American Peptides10 mg65 USD6.5 USD/mg2026-09-15Product page · Ad
Chameleon Peptides10 mg68.4 USD6.84 USD/mg2026-09-15Product page · Ad
Licensed Peptides30 mg76.99 USD2.57 USD/mg2026-09-15Product page · Ad

Questions about interpretation

What does the search “Semax protocol” mean?

“Protocol” is often used to mean a regimen. This page explains research and documented listings. It contains no doses, cycles or instructions for human use. An online regimen is not scientifically validated simply because it is widely shared.

Sources and data basis

These references come from the existing dataset. A link alone verifies neither a study claim nor supplier quality. Uncertainty remains explicit where records are undated or incomplete.

  • PubMed ID 14556513
  • Panikratova KR et al. 2020, Doklady Biological Sciences, Bd. 490, S. 9-11

Where to go next

Created with AI assistance. This new edition has not yet received independent editorial review.